Vergel Manalo

shutterstock_1074052646 (1)

That’s ODD: can your medicine benefit from incentives for treating rare disorders?

The time, resources, and costs of developing and marketing medicines are extensive – putting treatments for rare disorders at a distinct disadvantage since the potential return on investment is limited...
Pharma and medical devices

Beyond a business merger, diverse skills come together at Brandwood CKC

The merger of Brandwood Biomedical and Capital K Consulting brings together a team of seemingly different fields of expertise in medical devices and medicines respectively. Yet it aligns perfectly with...

Search

Recent Posts

Categories

Categories

Archives

Archives

Archives